Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors

Abstract

This review illustrates the recent understanding of amyloid-β oligomers' characteristics and toxicity-related pathways, along with inhibitors against Aβ aggregation.

Overview

Integrity signals

Registry

Crossref · 10.1039/c6cs00731g

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 51 references

Cited by

Metadata

Authors
Lee, S. J. C., Nam, E., Lee, H. J., Savelieff, M. G., & Lim, M. H.
Affiliations
  • Ulsan National Institute of Science and Technology (KR)
  • University of Michigan (US)
Corresponding author
Lim, Mi Hee
Venue
Chemical Society Reviews
Published
2017
Volume
46
Issue
2
Pages
310-323
ISSN
  • 0306-0012 (ISSN-L)
  • 1460-4744
OpenAlex
W2550762885
Cited by
576
References
51
Citations by year
2026: 38 · 2025: 69 · 2024: 72 · 2023: 75 · 2022: 66 · 2021: 78 · 2020: 60 · 2019: 54 · 2018: 45 · 2017: 18
FWCI
4.58
Type
journal article
Language
en
Open access
closed
Locations
  • Chemical Society Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
amyloid-beta oligomers, Alzheimer's disease, amyloid-beta aggregation, amyloid fibril formation, amyloidosis, amyloid-beta clearance
MeSH terms
Alzheimer Disease, Humans, Amyloid beta-Peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.